FDA Approves First Fast-Acting Drug for Depression That Works Within 1 Week

Indonesia Berita Berita

FDA Approves First Fast-Acting Drug for Depression That Works Within 1 Week
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 PreventionMag
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

FDA Approves First Fast-Acting Oral Drug for Clinical Depression That Works in 1 Week

The drug, Auvelity, from Axsome Therapeutics claims to start working within one week.

A new medication called Auvelity was just FDA-approved to treat major depressive disorder , also known as clinical depression, in as little as one week. The new “fast-acting” oral drug for clinical depression, from Axsome Therapeutics, could change the way we treat mental health.by the FDA. Auvelity is an N-methyl D-aspartate receptor antagonist, marking the first new type of medication to be approved for clinical depression in 60 years.

In short, most antidepressant drugs work on the same neurotransmitters like dopamine and serotonin, but Auvelity focuses on glutamate receptors instead,

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

PreventionMag /  🏆 141. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Vehicle-To-Grid Trials Taking Place In Massachusetts & New YorkVehicle-To-Grid Trials Taking Place In Massachusetts & New YorkVehicle to grid trial programs are happening in more places like Massachusetts, Brooklyn, and Florida as utilities get on board.
Baca lebih lajut »

Commentary: Benefits of Inflation Reduction Act far-rangingCommentary: Benefits of Inflation Reduction Act far-rangingThe Inflation Reduction Act, or IRA, will lower prescription drug, health care, and...
Baca lebih lajut »

Latest Covid Boosters Are Set to Roll Out Before Human Testing Is CompletedLatest Covid Boosters Are Set to Roll Out Before Human Testing Is CompletedThe FDA is expected to authorize modified versions of Covid-19 vaccines. The U.S. wants to roll them out before it’s too cold—but that’s before data comes in from human trials
Baca lebih lajut »



Render Time: 2025-03-12 23:12:07